An Update on the Use of Mesh in Pelvic Reconstructive Surgery

Abstract By 2008, the use of vaginal mesh in gynecologic surgery was at its peak. Unfortunately, the rise in transvaginal mesh use was accompanied by a significant rise in mesh-related complications. Over the last 5 years, the FDA has been very proactive in regulating the use of transvaginal mesh, and its use has declined substantially since FDA sanctions were placed. Mesh for the treatment of stress urinary incontinence and transabdominal repair of pelvic organ prolapse is still supported by the FDA as well as the gynecologic and urologic societies. Surgeons should exercise caution when using any type of surgical mesh for the treatment of pelvic floor disorders, and its use should remain in the hands of experienced pelvic floor surgeons in patients who meet strict criteria and are well informed about its potential risks and benefits.
Source: Current Obstetrics and Gynecology Reports - Category: OBGYN Source Type: research